ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 45029 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 45029; 2) Community: the network communities that were significantly associated with the response to NSC 45029; 3) Molecule: the relationships between components within communities and NSC 45029; 4) MDR: the compounds that were significantly associated with the NSC 45029.

NSC Compound Enrichment Correlation
NSC 736157 Null 0.0228801759885687 -0.1363208
NSC 740 Methotrexate 0.0228801759885687 0.14160963
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0228801759885687 0.061555941
NSC 744063 Null 0.0228801759885687 0.20646767
NSC 331935 CHALCONE ANALOG 0.0238174255956144 0.043080816
NSC 105014 Cladribine 0.0238174255956147 -0.10063795
NSC 129790 Null 0.0238174255956147 0.24085354
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0238174255956147 -0.0050382937
NSC 163443 Null 0.0238174255956147 -0.27612323
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0238174255956147 0.05827566
Total:76  Current:35    [First] [Prev] [Next] [Last]